Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Ludwig Kappos(University Hospital of Basel), Ralf Gold(St. Josef-Hospital), David H. Miller(University College London), David MacManus(University College London), Eva Havrdová(General University Hospital in Prague), Volker Limmroth(University Hospital Cologne), Chris H. Polman(Amsterdam UMC Location VUmc), Klaus Schmierer(University College London), Tarek Yousry(University College London), Minhua Yang(Biogen (United States)), Mefkûre Eraksoy(Istanbul University), Eva Meluzínová(University Hospital in Motol), Ivan Rektor(Masaryk University), Katherine Dawson(Biogen (United States)), Alfred Sandrock(Biogen (United States)), Gilmore O’Neill(Biogen (United States))
The Lancet
October 1, 2008
Cited by 479Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis